Michael C. Milone

Hospital of the University of Pennsylvania

Also affiliated with Parker Institute for Cancer Immunotherapy, University of Pennsylvania

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “Itacitinib (INCB039110), a JAK1 Inhibitor, Reduces Cytokines Associated with Cytokine Release Syndrome Induced by CAR T-cell Therapy”.

Itacitinib (INCB039110), a JAK1 Inhibitor, Reduces Cytokines Associated with Cytokine Release Syndrome Induced by CAR T-cell Therapy

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1739

N/A

2.6DataRank · unranked

93 citations

Roddy S. O’Connor, Michael T. Peel, Selene Nuñez-Cruz, John Leferovich, Ashish Juvekar +7 more

Immunotherapy targeting B cells and long-lived plasma cells effectively eliminates pre-existing donor-specific allo-antibodies

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101336

N/A

0.716DataRank · unranked

22 citations

Caroline Markmann, Ming Yu, Divyansh Agarwal, Susan Rostami, Wei Wang +21 more

Enhancing Chimeric Antigen Receptor T Cell Anti-tumor Function through Advanced Media Design

Molecular Therapy — Methods & Clinical Development(2020)10.1016/j.omtm.2020.07.008

N/A

0DataRank · unranked

64 citations

Francisco J. Martinez-Becerra, Аlyssa M. Master, Sarah A. Richman, David Heo, John Leferovich +10 more

Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality

UNC Libraries(2020)10.17615/2vfb-gr51

N/A

0DataRank · unranked

0 citations

Gordon J. Freeman, Victor Tkachev, Catarina Sacristán, Ian A. Blair, Govindarajan Thangavelu +30 more

A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia

Science Translational Medicine(2021)10.1126/scitranslmed.abg6986

N/A

0DataRank · unranked

146 citations

Morgan Hresko, Lora K. Picton, Leon Su, Michael J. Hollander, Selene Nuñez-Cruz +6 more

Debulking SARS-CoV-2 in saliva using angiotensin converting enzyme 2 in chewing gum to decrease oral virus transmission and infection

Molecular Therapy(2021)10.1016/j.ymthe.2021.11.008

N/A

0DataRank · unranked

69 citations

Smruti K. Nair, Nardana Esmaeili, Geetanjali Wakade, Naila Shahid, Prem Kumar Ganesan +21 more

Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidase

Molecular Therapy(2021)10.1016/j.ymthe.2021.11.014

N/A

0DataRank · unranked

32 citations

Radhika Thokala, Lexus R. Johnson, Edward Z. Song, John Leferovich, Vijay Bhoj +6 more

The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0308

N/A

0DataRank · unranked

40 citations

Adam D. Cohen, Simon F. Lacey, Megan M. Davis, Alfred L. Garfall, J. Joseph Melenhorst +11 more

High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms

Frontiers in Oncology(2021)10.3389/fonc.2021.664236

N/A

0DataRank · unranked

37 citations

Zev A. Binder, Yibo Yin, Logan Zhang, Jiasi Vicky Zhang, Daniel Y. Zhang +5 more

B‐cell maturation antigen chimeric antigen receptor T‐cell re‐expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor‐based combination therapy

British Journal of Haematology(2021)10.1111/bjh.17397

N/A

0DataRank · unranked

11 citations

Lifeng Tian, Alfred L. Garfall, J. Joseph Melenhorst, Simon F. Lacey, Edward A. Stadtmauer +10 more

High Affinity Chimeric Antigen Receptor with Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.04.429797

N/A

0DataRank · unranked

4 citations

Zev A. Binder, Yibo Yin, Logan Zhang, Jiasi Vicky Zhang, Daniel Y. Zhang +5 more

Rapid manufacturing of non-activated potent CAR T cells

Nature Biomedical Engineering(2022)10.1038/s41551-021-00842-6

N/A

0DataRank · unranked

289 citations

Joseph S. Durgin, Selene Nuñez-Cruz, Jai Patel, John Leferovich, Marilia Rita Pinzone +11 more

Changes in Bone Marrow Tumor and Immune Cells Correlate with Durability of Remissions Following BCMA CAR T Therapy in Myeloma

Blood Cancer Discovery(2022)10.1158/2643-3230.bcd-22-0018

N/A

0DataRank · unranked

111 citations

Adam D. Cohen, Akhilesh Kaushal, Alfred L. Garfall, Renee Julia Manalo, Allison R. Carr +8 more

The IAP antagonist birinapant enhances chimeric antigen receptor T cell therapy for glioblastoma by overcoming antigen heterogeneity

Molecular Therapy — Oncolytics(2022)10.1016/j.omto.2022.11.004

N/A

0DataRank · unranked

39 citations

Xin Wang, Benjamin Philipson, Qian Zhang, Radhika Thokala, Logan Zhang +7 more

Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells

Nature Biotechnology(2023)10.1038/s41587-022-01637-z

N/A

0DataRank · unranked

175 citations

Xuming Mao, Sílvio M. Vieira, Jinmin Lee, Darshil Patel, Eun Jung Choi +14 more

CD38 as a pan-hematologic target for chimeric antigen receptor T cells

Blood Advances(2023)10.1182/bloodadvances.2022007059

N/A

0DataRank · unranked

63 citations

Caroline Diorio, John Chukinas, Kimberly Veliz, Olga Shestova, Feng Shen +10 more

F77 antigen is a promising target for adoptive T cell therapy of prostate cancer

Biochemical and Biophysical Research Communications(2023)10.1016/j.bbrc.2023.09.018

N/A

0DataRank · unranked

7 citations

Selene Nuñez-Cruz, John Leferovich, Tyra Wentz, Atrish Bagchi, Michael C. Milone +2 more

Data from Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells

(2023)10.1158/2326-6066.c.6548833.v1

N/A

0DataRank · unranked

0 citations

Ji‐Hyun Lee, Maria C. Basil, Carmine Carpenito, Shinichiro Motohashi, John Scholler +14 more

DR5 CAR-T cells target melanoma and suppress MDSCs with minimal toxicity

Molecular Therapy(2025)10.1016/j.ymthe.2025.12.025

N/A

0DataRank · unranked

1 citations

Shujing Liu, Prithvi Sinha, Fang Liu, Xiaogang Zhang, Yeye Guo +19 more

DR5 CAR-T cells target solid tumors and suppress MDSCs with minimal toxicity

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.09.658618

N/A

0DataRank · unranked

0 citations

Shujing Liu, Prithvi Sinha, Fang Liu, Xiaogang Zhang, Yeye Guo +20 more

Viral vector-free generation of orthogonal IL-2–responsive CAR T cells through gene editing of IL-2 and its receptor

Blood Immunology & Cellular Therapy(2025)10.1016/j.bict.2025.100019

N/A

0DataRank · unranked

0 citations

Yihao Wu, Jee‐Eun Yang, Kevin N. Zhou, Eric Nigel Ebenezer Anand Manoharan, Tyra Wentz +16 more

Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris

Journal of Clinical Investigation(2020)10.1172/jci138416

N/A

0DataRank · unranked

157 citations

Daniel K. Lundgren, Xuming Mao, Sílvio M. Vieira, Selene Nuñez-Cruz, Erik F. Williams +9 more

Improved Tumor Specificity of Mesothelin (MSLN)-specific Killer Immunoglobulin Receptor (KIR)-based Chimeric Antigen Receptor (CAR) T cell therapy SynKIR-110 3562

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1353

N/A

0DataRank · unranked

0 citations

Yucel Yucel, Tam Truong, Megan C. Blair, Jun Xu, Michael C. Milone +2 more

4-1BB costimulation promotes CAR T cell survival through noncanonical NF-κB signaling

Science Signaling(2020)10.1126/scisignal.aay8248

N/A

0DataRank · unranked

222 citations

Roddy S. O’Connor, Michael J. May, Carl H. June, Steven Μ. Albelda, Michael C. Milone +1 more